0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Structure-based repurposing of anti-malaria drugs to inhibit RNA-dependent RNA polymerase domain of dengue virus [Conference Abstract] August 1, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Strengthening public pealth intervention through public health intelligence in Nigeria, 2022 to 2024 [Conference Abstract] August 1, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Standardization of death rate: Implications for variability in mortality and age-distribution of Lassa fever in Ondo State, Nigeria [Conference Abstract] August 1, 2025 by Allan Mwesiga
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 REALISE: A two-year study tracking Lassa fever seroprevalence and contributing risk factors in Guinea’s Gueckedou region [Conference Abstract] August 1, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Molecular characterisation of Lassa virus (Glycoprotein Complex Gene) in febrile patients in Plateau State, Nigeria [Conference Abstract] July 31, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 A multi-quarter assessment of sample rejection and cold chain deviations in Lassa fever surveillance in Nigeria, 2024–2025 [Conference Abstract] July 31, 2025 by Ernest Liuta
